Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silicos NV

www.silicos.be

Latest From Silicos NV

Silicos NV

Silicos NV's computational lead identification and development platform combines proprietary and commercial computational chemistry tools, and has potential in many indications such as cancer and infectious diseases, central nervous system disorders, and immunodeficiency diseases. The company is using its virtual fragment-based tools to create small molecules for both clients and for its own internal projects.
BioPharmaceutical

Start-Up Previews (10/2009)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "It’s Apples vs. Oranges in the PI3 Kinase Race," features profiles of Arno Therapeutics, Intellikine and Paloma Pharmaceuticals. Plus these Start-Ups Across Health Care: Mesynthes, Miracor Medical Systems, Silicos, Vantia and Vexim.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Belgium
  • Parent & Subsidiaries
  • Silicos NV
  • Senior Management
  • Wilfried Langenaeker, PhD, CEO
    Hans De Winter, PhD, CSO
  • Contact Info
  • Silicos NV
    Phone: (32) 11 350700
    Wetenschapspark 7
    Diepenbeek, 3590
    Belgium
UsernamePublicRestriction

Register